Cancer Biotherapy and Radiopharmaceuticals provides peer-reviewed research on cutting-edge therapeutic investigations and advancements in radioimmunotherapy for treating cancer. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.

 

The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments. 

 

Cancer Biotherapy and Radiopharmaceuticals coverage includes:

Antibody drug conjugates

Fusion toxins and immunotoxins

Nanoparticle therapy

Vascular therapy

Inhibitors of proliferation signaling pathways

 

 

Cancer Biotherapy and Radiopharmaceuticals（癌症生物  疗法和放射药物）提供有关尖端疗法的最新研究以及放射免疫疗法治疗癌症的进展的同行评审研究。它是唯一专门针对癌症生物疗法的期刊，涵盖单克隆抗体，细胞因子疗法，癌症基因疗法，基于细胞的疗法以及其他形式的免疫疗法。

 

该杂志包括有关放射免疫治疗进展的大量报道，以及放射性药物和放射性标记的肽在开发新的癌症治疗方法中的用途。 

 

癌症生物疗法和放射性药物的涵盖范围包括：

抗体药物偶联物

融合毒素和免疫毒素

纳米粒子疗法

血管疗法

增殖信号通路的抑制剂